Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44...(103 99 Deferred income taxe...),Health
Navigation Links
Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share
Date:11/10/2009
103 99 Deferred income taxes 118 21 (83) (94) Provision for losses on accounts receivable and inventory 42 36 156 135 (Gain) Loss on extinguishment of debt - - (2) 258 Other non-cash items 46 62 108 137 Changes in assets and liabilities, net of the effects of acquisitions and divestitures: Accounts receivable, net 23 67 207 (176) Inventories 186 35 367 (138) Prepaid expenses and other current assets 186 2 11 11 Accounts payable 48 119 (352) (16) Accrued and other liabilities (40) 205 (52) (152) Income taxes, net (145) (87) (148) (95) Class action settlement liability - - - (3,020) Other (7) (18) 109 (80) -- --- --- --- Net cash provided by (used in) operating activities 985 1,036 2,429 (872) --- ----- ----- ---- Net cash provided by (used in) discontinued operating activities - 7 (8) (18) Cash Flows from Investing Activities: Capital expenditures (209) (189) (709) (734) Proceeds from disposal of assets 7 14 13 28 Acquisition of businesses, net of cash acquired (1) (255) (48) (347) Accounts purchased
'/>"/>
| SOURCE Tyco International Ltd. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research
2. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
3. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
4. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
5. Allied Worlds Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference
6. Service Corporation International Announces Third Quarter 2009 Financial Results
7. Stenum Hospital Kicks off International Rollout of M6 Artificial Lumbar Disc Replacement Surgery
8. FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDAs international posts, LASIK eye surgery, and FDA MedWatch safety alerts
9. Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call
10. Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award
11. MediSend International Joins the Clinton Global Initiative With the Afghanistan Health and Human Resource Initiative
Post Your Comments:
(Date:11/25/2009)...wire/--TheBayAreaAirQualityManagementDistrictisiss... Alert forThursday,November26,2009whichbansbu...bothindoorsandoutdoors. ,, "Cold,stillweatherwi...kBroadbent,executiveofficeroftheAirDistrict."We,re...ghborsandfellowcommunitymembersthisThanksgiving,an...
(Date:11/25/2009)...r cancer who were treated with cisplatin-based che...neurological side effects and Raynaud-like phenome...y, according to a new study published online Novem...itute . , Marianne Brydy, M.D., of the Departmen...ergen, Norway, and colleagues conducted a cross-se...
(Date:11/25/2009)...ew out of a collaboration between UCLA engineers a...nearly 10 million Americans who suffer from periph...ning of the arteries, peripheral arterial disease,...narrowed arteries reduce blood flow to the limbs. ...r disease, heart attack and stroke, and its progre...
(Date:11/25/2009)... short to draw definite conclusions, experts say,... -- In diabetic patients with blocked coronary art...es at one year whether patients undergo bypass sur...hers report. , Bypass surgery has been the stan... artery disease. However, less invasive approaches...
(Date:11/25/2009)...on and treatment clinics to resume Monday, Nov. 30...mber 25, 2009 -- Centegra Health System is continu...shots at four Centegra Primary Care (CPC) vaccinat...arrived. The clinics are at CPC sites in Huntley, ...en as follows: , From 4:30 to 7:30 p...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009[0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects[0] Engineers, doctors at UCLA develop novel material that could help fight arterial disease[0] Stenting May Equal Bypass for Diabetic Heart Patients [0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1
...nt on incorporating the patient’s voice into cance...estigators have sought out the best //practices, p...lity of life (QOL) assessment. Their findings were...sychological, emotional, social and spiritual well...
...st-published research study by Dr. R Preston Mason... that astaxanthin, a relatively //unknown caroteno... viable scaffold for a new therapy to treat cardio...necdotal human data, the results of the Mason stud...
...ary is Alzheimer Awareness Month. Two experts from... are available to comment on the effects of Alzhei... on risk factors and potential cures. The availabi...ians aged 65 and over have AD. As populations arou...
...nty-four percent of men treated with a combination...ation therapy for prostate cancer are cured of the...ording to a study. //
This study was conducte... two different types of radiation therapy, to prol...
...millions of Americans afflicted with Type 1 and 2 ...ing: heart and kidney disease; //nerve damage and ...al disorders and hypoglycemia.
Another major ...e sensitive area at the back of the eye). Overall,...
...e millions of Americans place fitness as one of th...uscle tone and overall appearance, cancer survivor...s at The University of Texas M. D. Anderson Cancer... bay. Karen Basen-Engquist, Ph.D., principal inves...
Other Medicine News:Health News:Better Understanding of Quality of Life Assessments 2Health News:Better Understanding of Quality of Life Assessments 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3Health News:Alzheimer’s Disease: Let’s Weigh-In on the Ris 2Health News:Vision Loss Can Be Prevented in People With Diabetes 2Health News:Vision Loss Can Be Prevented in People With Diabetes 3Health News:The Shape of Health to Come 2Better Understanding of Quality of Life AssessmentsStudy Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane ModelAlzheimer’s Disease: Let’s Weigh-In on the RisRadiation Therapy Combo Cures Prostate Cancer Long-TermVision Loss Can Be Prevented in People With DiabetesThe Shape of Health to Come
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...re/--RegadoBiosciences,aprivatelyheldcompanyleadin...ontrolagents,announcedthatDavidMazzo,PhD,CEOandPre...HealthCareConferenceattheNewYorkPalaceHotelinNewYo...ST)onTuesday,December1andwillincludeanoverviewofth...program,theanticoagulantsystem,REG1.Thehealthcarei...
(Date:11/25/2009)...ire/--SwissrayInternational,Inc.aleadingmanufactur...edtodaythatitsoperationshavebeenacquiredbyaprivate...ay,smedicalimagingbrand.Theacquisitionincludedalla...nventory.After25yearsofsuccessandgrowthSwissrayisn...mentswithstableandsteadygrowth. ,, "Swissrayhas...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Parameter Generation and Control Launches New Catalog 26quot 3BPharmaceutical Stability Solutions 26quot 3B 14328 1Parameter Generation and Control Launches New Catalog 26quot 3BPharmaceutical Stability Solutions 26quot 3B 14328 2Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 1Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 2Major Central Florida Label Printer Creates On Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers 58739 3Your Eyes May Help Diagnose Heart Disease and Stroke 58736 1Your Eyes May Help Diagnose Heart Disease and Stroke 58736 2Your Eyes May Help Diagnose Heart Disease and Stroke 58736 3[0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High[0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009[0] Swissray International Announces New Ownership
...., May 5 Vaccines don,t just keep children,health... who can earn,higher wages and save more money, ac...t the Harvard School of Public Health., Bloom, wh...n developing,countries, will be the keynote speake...h sponsored by the National Foundation for Infecti...
...o., May 5 N30 Pharma (N30), a,biopharmaceutical c...commercialization of drugs that target endogenous ...sfully completed Phase I study of N30-201,in patie...hy volunteers.,N30 intends to develop N30-201 for ...iseases, including Cystic Fibrosis and asthma., "...
Other Medicine Technology:Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 2Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 3Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 4Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 5Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 6N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2...LARK CLOtest Rapid Urease Test is recognized by me...ease tests because of its accuracy, convenience an...rshall, MD. who, along with Robin Warren, M.D. was...pylori and gastric ulcers. Today, CLOtest has beco...
SERIM PYLORITEK VP TEST KIT
...ue H.pylori gII test is a lateral-flow immuno-chro...ive detection of IgG antibodies specific to Helico...d. It utilizes a convenient, non-invasive, and eas... the diagnosis of H.pylori infection in patients w...
...P is a visually read, qualitative immunochromatogr...H. pylori, a bacterium that grows in the stomach a...e gastric cancers. FlexSure HP, available for use ... the physician with the opportunity to perform "on...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |